Lipella Pharmaceuticals I... (LIPO)
NASDAQ: LIPO
· Real-Time Price · USD
0.61
0.00 (0.00%)
At close: Sep 25, 2025, 10:08 AM
0.61
0.00%
Pre-market: Sep 25, 2025, 10:08 AM EDT
0.00% (1D)
| Bid | 0.6 |
| Market Cap | 2.82M |
| Revenue (ttm) | 216.37M |
| Net Income (ttm) | -1.31B |
| EPS (ttm) | -3.33 |
| PE Ratio (ttm) | -0.18 |
| Forward PE | -0.04 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 0.62 |
| Volume | 1,146 |
| Avg. Volume (20D) | 6,344 |
| Open | 0.61 |
| Previous Close | 0.61 |
| Day's Range | 0.61 - 0.61 |
| 52-Week Range | 0.53 - 7.31 |
| Beta | -0.09 |
| Ex-Dividend Date | n/a |
About LIPO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LIPO
Website n/a
7 months ago
+41.64%
Lipella Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
7 months ago
+80.23%
Lipella Pharmaceuticals shares are trading higher after the company received FDA approval for an expanded access program for LP-310 in oral lichen planus.
